Annals of Hepatology

2.2(top 20%)

impact factor

3.4K(top 5%)

papers

40.3K(top 10%)

citations

68(top 10%)

h-index

2.4(top 20%)

impact factor

4.1K

all documents

42.7K

doc citations

97(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Bile Acid Physiology	Annals of Hepatology	2017	306
2	Prevalence of non-alcoholic fatty liver disease: population based study	Annals of Hepatology	2007	293
3	Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study	Annals of Hepatology	2013	252
4	Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)	Annals of Hepatology	2009	244
5	The Role of the Gut Microbiota in Bile Acid Metabolism	Annals of Hepatology	2017	210
6	Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens	Annals of Hepatology	2010	192
7	AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis	Annals of Hepatology	2008	187
8	Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport	Annals of Hepatology	2017	172
9	Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis	Annals of Hepatology	2013	167
10	The importance of redox state in liver damage	Annals of Hepatology	2004	158
11	Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial	Annals of Hepatology	2011	153
12	S-adenosylmethionine metabolism and liver disease	Annals of Hepatology	2013	152
13	Prevalence of non-alcoholic fatty liver disease: population based study	Annals of Hepatology	2007	145
14	Management Strategies for Liver Fibrosis	Annals of Hepatology	2017	144
15	Metabolic syndrome and non-alcoholic fatty liver disease	Annals of Hepatology	2009	143
16	Liver fibrosis and inflammation. A review	Annals of Hepatology	2003	141
17	What is changing in indications and treatment of hepatic hemangiomas. A review	Annals of Hepatology	2014	137
18	The role of zinc in liver cirrhosis	Annals of Hepatology	2016	137
19	Gut microbiota and nonalcoholic fatty liver disease	Annals of Hepatology	2012	136
20	Biliary secretion and excretion in health and disease: Current concepts	Annals of Hepatology	2007	127
21	Hepatocellular carcinoma. An overview	Annals of Hepatology	2006	125
22	New Insights About Albumin and Liver Disease	Annals of Hepatology	2018	125
23	The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes	Annals of Hepatology	2017	123
24	The prevalence of nonalcoholic fatty liver disease in the Americas	Annals of Hepatology	2014	122
25	Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress	Annals of Hepatology	2009	119
26	Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compounds	Annals of Hepatology	2014	118
27	NASH and cryptogenic cirrhosis: A histological analysis	Annals of Hepatology	2009	117
28	Dipeptidyl peptidase IV (DDP IV) in NASH patients	Annals of Hepatology	2007	115
29	Cholestasis: human disease and experimental animal models	Annals of Hepatology	2003	113
30	Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study	Annals of Hepatology	2013	111
31	Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)	Annals of Hepatology	2009	110
32	Kava hepatotoxicity. A clinical review	Annals of Hepatology	2010	104
33	Post-liver transplantation medical complications	Annals of Hepatology	2006	103
34	Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients	Annals of Hepatology	2008	99
35	Epidemiology of hepatocellular carcinoma in sub-Saharan Africa	Annals of Hepatology	2013	96
36	Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions	Annals of Hepatology	2007	95
37	Advanced hepatocellular carcinoma. Review of targeted molecular drugs	Annals of Hepatology	2011	94
38	Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease	Annals of Hepatology	2008	91
39	Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements	Annals of Hepatology	2016	89
40	Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis	Annals of Hepatology	2017	89
41	Reversibility of liver fibrosis	Annals of Hepatology	2009	88
42	Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy	Annals of Hepatology	2003	86
43	Liver disease during pregnancy: acute viral hepatitis	Annals of Hepatology	2006	86
44	Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data	Annals of Hepatology	2005	84
45	Severe hepatotoxicity by Indian Ayurvedic herbal products: A structured causality assessment	Annals of Hepatology	2009	84
46	Hepatogenous diabetes. Current views of an ancient problem	Annals of Hepatology	2009	84
47	Association between butyrylcholinesterase activity and low-grade systemic inflammation	Annals of Hepatology	2012	84
48	Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease	Annals of Hepatology	2014	84
49	Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease	Annals of Hepatology	2013	83
50	Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis	Annals of Hepatology	2017	83

Scientometrics

Overviews

Citing Bodies

Annals of Hepatology

Top Articles